These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25682933)

  • 1. Stereotactic body radiotherapy for liver metastases.
    Aitken KL; Hawkins MA
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):307-15. PubMed ID: 25682933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiotherapy for oligometastatic disease.
    Hanna GG; Landau D
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):290-7. PubMed ID: 25770653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic ablative body radiotherapy for lung cancer.
    Franks KN; Jain P; Snee MP
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stereotactic body radiation therapy (SBRT) in the treatment of liver metastases: state of the art].
    De Bari B; Guillet M; Mornex F
    Cancer Radiother; 2011 Feb; 15(1):72-6. PubMed ID: 21216647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiation therapy for liver metastases.
    Dawood O; Mahadevan A; Goodman KA
    Eur J Cancer; 2009 Nov; 45(17):2947-59. PubMed ID: 19773153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of individualized stereotactic body radiotherapy of liver metastases.
    Lee MT; Kim JJ; Dinniwell R; Brierley J; Lockwood G; Wong R; Cummings B; Ringash J; Tse RV; Knox JJ; Dawson LA
    J Clin Oncol; 2009 Apr; 27(10):1585-91. PubMed ID: 19255313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
    Ahmed KA; Torres-Roca JF
    Cancer Control; 2016 Jan; 23(1):21-9. PubMed ID: 27009453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial).
    Mercier C; Dirix P; Meijnders P; Vermeulen P; Van Laere S; Debois H; Huget P; Verellen D
    Radiat Oncol; 2018 Aug; 13(1):152. PubMed ID: 30126440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
    Iyengar P; Westover K; Timmerman RD
    Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials of stereotactic ablative radiotherapy for prostate cancer: updates and future direction.
    Musunuru HB; Loblaw A
    Future Oncol; 2015; 11(5):819-31. PubMed ID: 25757684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy for liver metastases.
    Schefter TE; Kavanagh BD
    Semin Radiat Oncol; 2011 Oct; 21(4):264-70. PubMed ID: 21939855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Hepatic Toxicity in Primary and Metastatic Liver Cancers after Stereotactic Ablative Radiotherapy Using 3 Fractions.
    Bae SH; Kim MS; Jang WI; Cho CK; Yoo HJ; Kim KB; Han CJ; Park SC; Lee DH
    J Korean Med Sci; 2015 Aug; 30(8):1055-61. PubMed ID: 26240482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
    Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization.
    Song DY; Kavanagh BD; Benedict SH; Schefter T
    Oncology (Williston Park); 2004 Oct; 18(11):1419-30; discussion 1430, 1432, 1435-6. PubMed ID: 15609470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
    Méndez Romero A; Wunderink W; Hussain SM; De Pooter JA; Heijmen BJ; Nowak PC; Nuyttens JJ; Brandwijk RP; Verhoef C; Ijzermans JN; Levendag PC
    Acta Oncol; 2006; 45(7):831-7. PubMed ID: 16982547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic ablative radiotherapy for oligometastatic disease in liver.
    Kim M; Son SH; Won YK; Kay CS
    Biomed Res Int; 2014; 2014():340478. PubMed ID: 24868526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolving role of radiotherapy in treatment of oligometastatic NSCLC.
    Bergsma DP; Salama JK; Singh DP; Chmura SJ; Milano MT
    Expert Rev Anticancer Ther; 2015; 15(12):1459-71. PubMed ID: 26536370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-guided stereotactic ablative radiotherapy for the liver: a safe and effective treatment.
    Van De Voorde L; Vanneste B; Houben R; Damen P; van den Bogaard J; Lammering G; Dejong K; de Vos-Geelen J; Buijsen J; Öllers M; Berbée M; Lambin P
    Eur J Surg Oncol; 2015 Feb; 41(2):249-56. PubMed ID: 25468743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiation therapy for liver metastasis--case report and review of the literature. The role of patient preparation, treatment planning and its delivery.
    Adamczyk M; Fundowicz M
    J Cancer Res Ther; 2014; 10(3):519-25. PubMed ID: 25313731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases.
    Saluja R; Cheung P; Zukotynski K; Emmenegger U
    Urol Oncol; 2016 May; 34(5):225-32. PubMed ID: 27008982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.